Erratum: Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats (Journal of Cerebral Blood Flow and Metabolism (2011) 31 (486-493) doi:10.1038/jcbfm.2010.111);Imaging upregulated brain arachidonic acid metabolism in HIV-1 transgenic rats

Journal of Cerebral Blood Flow and Metabolism

Volumn 31, Issue 2, 2011, Pages 486-493

  Basselin, Mireille ^a   Ramadan, Epolia ^a   Igarashi, Miki ^a   Chang, Lisa ^a   Chen, Mei ^a   Kraft, Andrew D ^b   Harry, G Jean ^b   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

arachidonic acid; brain imaging; eicosanoids; HIV 1

Indexed keywords

ARACHIDONIC ACID; CALCIUM; CARBON 11; CYCLOOXYGENASE 2; ICOSANOID; LEUKOTRIENE B4; PHOSPHOLIPASE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BEHAVIOR DISORDER; BRAIN DISEASE; BRAIN METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NEUROIMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SOMATOSENSORY CORTEX; TRANSGENE; UPREGULATION;

EID: 79551639429     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.122     Document Type: Erratum

References (39)

1. Anthony IC, Bell JE (2008) The neuropathology of HIV/ AIDS. Int Rev Psychiatry 20:15-24
2. Bagetta G, Corasaniti MT, Paoletti AM, Berliocchi L, Nistico R, Giammarioli AM, Malorni W, Finazzi-Agro A (1998) HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxy-genase type 2 (COX-2). Biochem Biophys Res Commun 244:819-24
3. Basselin M, Villacreses NE, Lee H-J, Bell JM, Rapoport SI (2007) Flurbiprofen, a cyclooxygenase inhibitor, reduces the brain arachidonic acid signal in response to the cholinergic muscarinic agonist, arecoline, in awake rats. Neurochem Res 32:1857-67
4. Bosetti F (2007) Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models. J Neurochem 102:577-86
5. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-54
6. Brust D, Polis M, Davey R, Hahn B, Bacharach S, Whatley M, Fauci AS, Carrasquillo JA (2006) Fluorodeoxyglu-cose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS (London, England) 20:985-93
7. Chang YC, Kim HW, Rapoport SI, Rao JS (2008) Chronic NMDA administration increases neuroinflammatory markers in rat frontal cortex: cross-talk between excitotoxicity and neuroinflammation. Neurochem Res 33:2318-23
8. D'Aversa TG, Eugenin EA, Berman JW (2005) NeuroAIDS: contributions of the human immunodeficiency virus-1 proteins Tat and gp120 as well as CD40 to microglial activation. J Neurosci Res 81:436-46
9. 14C]arachidonate to examine regional brain lipid metabolism in una-nesthetized rats. J Neurosci Res 24:413-23
10. DeMar JC Jr, Lee HJ, Ma K, Chang L, Bell JM, Rapoport SI, Bazinet RP (2006) Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phos-pholipids of adult rats. Biochim Biophys Acta 1761: 1050-9
11. Esposito G, Giovacchini G, Liow JS, Bhattacharjee AK, Greenstein D, Schapiro M, Hallett M, Herscovitch P, Eckelman WC, Carson RE, Rapoport SI (2008) Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med 49:1414-21
12. 2 isoprostanes and docosanoids following decapitation-induced ischemia, measured in high-energy micro-waved rat brain. J Lipid Res 49:1990-2000
13. Flora G, Pu H, Hennig B, Toborek M (2006) Cyclooxy-genase-2 is involved in HIV-1 Tat-induced inflammatory responses in the brain. Neuromolecular Med 8:337-52
14. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509
15. Griffin DE, Wesselingh SL, McArthur JC (1994) Elevated central nervous system prostaglandins in human immunodeficiency virus-associated dementia. Ann Neurol 35:592-7
16. 2 activity and gene expression are stimulated by tumor necrosis factor: dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA 90:4475-9
17. 2 inhibitor blocks negative inotropic effect of HIV gp120 on cardiac myocytes. J Mol Cell Cardiol 40:131-7
18. Kaufmann WE, Andreasson KI, Isakson PC, Worley PF (1997) Cyclooxygenases and the central nervous system. Prostaglandins 54:601-24
19. Killebrew DA, Troelstrup D, Valcour V, Williams A, Aguon J, Sapalo D, Shikuma C, Ratto-Kim S, Shiramizu B (2005) Discordant plasma and cerebral spinal fluid cytokines/chemokines in relation to HIV-1-associated dementia. Cell Mol Biol (Noisy-le-Grand, France) 51(Suppl):OL745-54
20. Lashomb AL, Vigorito M, Chang SL (2009) Further characterization of the spatial learning deficit in the human immunodeficiency virus-1 transgenic rat. J Neurovirol 15:14-24
21. Lee H, Villacreses NE, Rapoport SI, Rosenberger TA (2004) In vivo imaging detects a transient increase in brain arachidonic acid metabolism: a potential marker of neuroinflammation. J Neurochem 91:936-45
22. Lee HJ, Rao JS, Chang L, Rapoport SI, Bazinet RP (2008) Chronic N-methyl-D-aspartate administration increases the turnover of arachidonic acid within brain phos-pholipids of the unanesthetized rat. J Lipid Res 49: 162-8
23. May S, Letendre S, Haubrich R, McCutchan JA, Heaton R, Capparelli E, Ellis R (2007) Meeting practical challenges of a trial involving a multitude of treatment regimens: an example of a multi-center randomized controlled clinical trial in neuroAIDS. J Neuroimmune Pharmacol 2:97-104
24. Moolwaney AS, Igwe OJ (2005) Regulation of the cyclo-oxygenase-2 system by interlukin-1beta through mitogen-activated protein kinase signaling pathways: a comparative study of human neuroglioma and neuro-blastoma cells. Brain Res Mol Brain Res 137:202-12
25. 2s and cyclo-oxygenases in immediate and delayed prostanoid bio-synthetic pathways. J Biol Chem 274:3103-15
26. Norman JP, Perry SW, Reynolds HM, Kiebala M, De Mesy Bentley KL, Trejo M, Volsky DJ, Maggirwar SB, Dewhurst S, Masliah E, Gelbard HA (2008) HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mito-chondrial hyperpolarization. PloS One 3:e3731
27. 2 in the normal rat brain. J Hirnforsch 39:391-400
28. Paxinos G, Watson C (1987) The Rat Brain in Stereotaxic Coordinates. 3rd ed. New York, NY: Academic Press
29. 2 and its transcription factor, activator protein-2. J Neurochem 102:1918-27
30. 14C]urea pharmacokinetics. Am J Physiol 242:R339-48
31. Reid W, Sadowska M, Denaro F, Rao S, Foulke J, Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O'Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 98:9271-6
32. Robinson PJ, Noronha J, DeGeorge JJ, Freed LM, Nariai T, Rapoport SI (1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Brain Res Rev 17:187-214
33. 2-mediated fatty acid release from brain phospho-lipids. Biochim Biophys Acta 1791:697-705
34. Rosenberger TA, Villacreses NE, Hovda JT, Bosetti F, Weerasinghe G, Wine RN, Harry GJ, Rapoport SI (2004) Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem 88:1168-78. Erratum in: J Neurochem (2004) 90:255
35. 2 enzymes: classification and characterization. Biochim Biophys Acta 1488:1-19
36. 4. Biochem Biophys Res Commun 237:413-8
37. 2 and n-3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuro-inflammation. Int J Dev Neurosci 22:551-7
38. Wesselingh SL, Glass J, McArthur JC, Griffin JW, Griffin DE (1994) Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol 4:199-206
39. 2. Anal Biochem 269:278-88